Interestingly, recent work suggests that AA patients with t(11;14) showed a trend toward shorter median progression-free survival (PFS) compared with AA without the presence of t(11;14); however, t(11;14) did not impact PFS in non-AA patients 33 .
← all excerpts
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.
2
—
—
The sentences
TP53 somatic mutations also appeared to be more common in CA (6%) than AA (0%); however, this difference did not reach statistical significance.